London, ON, CANADA, Release: August 12, 2021 –Alimentiv, Inc. announced today the launch of their new eTMF solution in partnership with Veeva Vault eTMF, offering sponsors real-time data and secure access to all clinical documentation throughout the clinical trial lifecycle.

As part of its strategy to modernize its technology landscape, Alimentiv selected Vault eTMF to improve efficiency, simplify workflows, and provide transparency into the real-time status of the TMF. Vault eTMF fully supports the industry’s TMF Reference model, enabling Alimentiv and its partners to locate documents easily and quickly.

As Alimentiv continues to evolve and expand into new therapeutic areas, functional units, and geographies, executing smart, feasible studies at reduced costs are critical to sustaining strategic advantage. Leveraging technology to provide high value differentiated services and adapting to complex trials is key to Alimentiv’s strategy and vision.

“This is a big step for our company and our valued investigators, study coordinators, CRA’s in the field and our clients. This will create a real time status oversight of the study documents for all parties involved” said Daniel Philpott, Director Clinical Operations in Monitoring & Site Management.

Vault eTMF has been designed to address an enterprise view of clinical operations management where common processes are consolidated in the same platform as opposed to separate applications which:

  • Allows common information to be defined once, reducing data duplications
  • Promotes the integration of clinical operational processes around a common information and technology model supporting application consolidation
  • Simplifying the technology and applications so that the number of systems can be reduced allowing multiple stakeholders to access different business processes based on their roles and responsibilities
  • Provides an enterprise view of clinical operations satisfying both operational and strategic needs of the business.
  • Allows for a higher level of collaboration at all levels of the clinical trial experience, impacting sponsors, investigators, vendors, and regulatory authorities, as well as internal collaborators within Alimentiv.

For more details, please refer to

Veeva eTMF will be activated effective today, Thursday, August 12. All new studies will be launched in the eTMF during study start-up.


Fern Livingstone, Manager, Marketing & Communications

Tel: (519) 639-3205


About Alimentiv

Alimentiv (CRO) is a global research organization providing clinical trials, central image management, and precision medicine services to the pharmaceutical and biotechnology industries. Headquartered in London Ontario, Alimentiv employs approximately 400 people across its operations in Canada, the United States, Europe, Asia-Pacific, and Latin America. Its unique model combines the efforts of leading, internationally recognized academic researchers with operational experts to offer integrated solutions to its customers. Founded in 1986 at the Robarts Research Institute, the clinical trials division was initially led by Dr. Henry Barnett. In 1997, Dr. Brian Feagan, Professor of Medicine, Epidemiology & Biostatistics at Western University assumed leadership and built upon the foundation of academic excellence by focusing the organization on Inflammatory Bowel Disease (IBD) research. Over the past 20 years, Alimentiv has become recognized as an expert in clinical trial design, central image management solutions, outcome measure development, and precision medicine for drug development in IBD. Today, Alimentiv provides services in over 60 countries worldwide, collaborates with leading academic research institutions across the globe, and partners with many of the leading pharmaceutical and biotechnology organizations to bring new and improved treatment options to patients.

Additional Information

For more on Alimentiv:

Connect with Alimentiv on LinkedIn:

Follow @alimentiv on Twitter:

Like Alimentiv on Facebook:

About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 850 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit